The_DT
p53_NN
paradox_NN
in_IN
the_DT
pathogenesis_NN
of_IN
tumor_NN
progression_NN
._.

Recent_JJ
evidence_NN
suggests_VBZ
that_IN
the_DT
p53_NN
molecule_NN
appears_VBZ
in_IN
two_CD
different_JJ
forms_NNS
:_:
the_DT
mutant_JJ
p53_NN
that_WDT
stimulates_VBZ
tumor_NN
progression_NN
,_,
and_CC
wild_JJ
type_NN
p53_NN
that_WDT
inhibits_VBZ
tumor_NN
progression_NN
._.

In_IN
addition_NN
,_,
it_PRP
has_VBZ
been_VBN
established_VBN
that_IN
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
can_MD
activate_VB
the_DT
expression_NN
of_IN
wild_JJ
type_NN
p53_NN
in_IN
concert_NN
with_IN
the_DT
nuclear_JJ
transcription_NN
factor_NN
,_,
NF-kappa_NN
B_NN
._.

Both_CC
TNF-alpha_NN
and_CC
NF-kappa_NN
B_NN
are_VBP
also_RB
involved_VBN
in_IN
the_DT
stimulation_NN
of_IN
the_DT
pathway_NN
that_WDT
leads_VBZ
to_TO
the_DT
expression_NN
of_IN
major_JJ
histocompatibility_NN
complex_NN
-LRB-_-LRB-
MHC_NN
-RRB-_-RRB-
class_NN
I_CD
molecules_NNS
and_CC
,_,
hence_RB
,_,
antigen_NN
presentation_NN
to_TO
the_DT
T_NN
cells_NNS
._.

In_IN
this_DT
paper_NN
we_PRP
shall_MD
advance_VB
the_DT
hypothesis_NN
that_IN
:_:
-LRB-_-LRB-
i_LS
-RRB-_-RRB-
TNF-alpha_NN
indirectly_RB
controls_VBZ
immune_JJ
surveillance_NN
;_:
and_CC
-LRB-_-LRB-
ii_LS
-RRB-_-RRB-
TNF-alpha_NN
controls_VBZ
DNA_NN
repair_NN
and_CC
tumor_NN
suppression_NN
through_IN
the_DT
regulation_NN
of_IN
wild_JJ
type_NN
p53_NN
._.

Thus_RB
,_,
it_PRP
is_VBZ
hypothesized_VBN
that_IN
elevated_JJ
TNF-alpha_NN
is_VBZ
primarily_RB
responsible_JJ
for_IN
promoting_VBG
tumor_NN
progression_NN
._.

